Search Within

Jae Hong Park

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (11)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (32)
  2. Center for Hematologic Malignancies (32)
  3. Department of Medicine (32)
  4. GSK Faculty (32)
  5. Hematologic Malignancies, Division of (32)
  6. Human Oncology and Pathogenesis Program (32)

More Groups

People
  1. Martin Tallman (18)
  2. Ross Levine (15)
  3. Omar Abdel-Wahab (13)
  4. Stephen Chung (11)
  5. Maria Palomba (10)
  6. Young Rock Chung (10)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (2)
  5. 2021 (1)
  6. 2019 (2)

More Years

Publications
  1. Blood (15)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Blood Advances (1)
  4. Blood Cancer Discovery (1)
  5. Cancer Cell (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (2)
  5. American Association for the Advancement of Science (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical comprehensive genomic profiling of B-acute lymphoblastic leukemia identifies targetable kinase pathway mutations in a significant subset of cases
    Meeting Abstract

    Yao, J. J. ; Arcila, M.; Shukla, N.; Kobos, R.; Park, J.; Douer, D.; Wang, L.; Roshal, M.; Maslak, P.; Levine, R.; more...
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Clinical comprehensive genomic profiling of B-acute lymphoblastic leukemia identifies targetable kinase pathway mutations in a significant subset of cases
    Meeting Abstract

    Yao, J. J. ; Arcila, M.; Shukla, N.; Kobos, R.; Park, J.; Douer, D.; Wang, L.; Roshal, M.; Maslak, P.; Levine, R.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders
    Meeting Abstract

    Kim, E.; Chung, S. S.; Park, J. H.; Chung, Y. R.; Lito, P.; Feldstein, J.; Hu, W. H.; Beguilin, W.; Monette, S.; Duy, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic analysis of serial samples from CLL patients identifies clonal events associated with disease progression
    Meeting Abstract

    Gardner, J. R.; Nahas, M.; He, J.; Aumann, S.; Gonen, M.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Brafv600e mutations in hematopoietic stem cells of hairy cell leukemia patients suggests a stem cell origin
    Meeting Abstract

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Feldstein, J.; Hu, W.; Rampal, R.; Patel, M.; Kim, M. K.; Huberman, K.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia
    Journal Article

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Lito, P.; Teruya-Feldstein, J.; Hu, W.; Béguelin, W.; Monette, S.; Duy, C.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Extensive high-depth sequencing of longitudinal CLL samples identifies frequent mutations in MAP kinase signaling and novel mutations activating notch and beta-catenin
    Meeting Abstract

    Gardner, J. R.; Nahas, M. K.; He, J.; Patel, M.; Knapp, K. M.; Palomba, M. L.; Yelensky, R.; Donahue, A. L.; Otto, G. A.; Arcila, M.; more...
    Blood (2013)

    Fulltext@MSK | Save